AzTrials
AzTrials

Radius Fracture Distal3D-castNCT05346926

Overnight and In-house 3D-printed Patient-specific Casts for Non-operative Treatment of Distal Radius Fractures

A study testing 3D-printed cast and Conventional cast in people with Radius Fracture Distal, run by Alissa Gubeli at 1 site in Switzerland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this prospective randomized trial is the acquisition and evaluation of data to assess the relevance, feasibility and safety of forearm casts based on 3D-printing technology in the nonoperative treatment of distal radius fractures. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Radius Fracture Distal
What is being tested?
3D-printed cast and Conventional cast
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteSwitzerland
Study dates
1 Mar 2020to 31 Dec 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Informed Consent as documented by signature (Appendix Informed Consent Form)
  • Undisplaced or minimally displace distal radius fractures

Who cannot join

  • Age < 18yrs.
  • Dorsal dislocation (dp angle) >20°
  • Palmar dislocation
  • Ad latus dislocation
  • Radio-/ulnar angulation in the coronary plane
  • Symptoms of neurologic affection (Median nerve)
Show all 14Show fewer
  • Bilateral fractures
  • Previous ipsilateral distal radius fracture
  • The patient is unable to give informed consent due to physical or mental impairment
  • The patient is unavailable for follow-up examinations (foreign country, Polytrauma, etc)
  • The patient is under legal custodianship
  • C2- or Drug-abuse or expected incompliance
  • Hypersensitivity/Allergy to one or more components of the used casts
  • Pregnancy/Intention to become pregnant during the course of the study

Trial locations and contacts

1 site in 1 country.

Switzerland1 site
  • Kantonsspital Baselland

    Bruderholz, Basel-Landschaft, 4101

Other trials in Switzerland

About this study

Official title: Overnight and In-house 3D-printed Patient-specific Casts for Non-operative Treatment of Distal Radius Fractures - a Prospective Randomized Trial

The aim of this prospective randomized trial is the acquisition and evaluation of data to assess the relevance, feasibility and safety of forearm casts based on 3D-printing technology in the nonoperative treatment of distal radius fractures.

Read the detailed description

The study design is planned according to similar studies investigating the treatment of distal radius fractures.

Upon the patient's arrival at the emergency unit, the distal radius fracture is examined following the same scheme as before. The wrist is x-rayed in two planes. If there is a distal radius fracture and none of the exclusion criteria apply, the patient is included in the study after giving their consent in writing. The patients are then assigned to the "conventional cast" group (Group A) or the "3D print cast" group (Group B) in randomized trial, either immediately during the emergency consultation or within a week during hand surgery consultation hours. For initial immobilization, a thermoplastic cast splint is used as before. Depending on the randomization, the cast is changed to a Scotchcast cast (Group A) or a 3D printed cast (Group B). Further treatment of both groups occurs based on the same algorithm as before (see below).

The cast for Group B are produced using 3D print technology based on software by a Belgian company, our collaborators: The patient's forearm is scanned with a tablet (duration: approx. 5 min), whereupon the cast is printed overnight according to the scan (duration: approx. 4h) and adjusted to the patient during the next appointment.

The patients are examined after 1, 6, 12, 26 and 52 weeks in the outpatient clinic. Follow up x rays, patient satisfaction and clinical efficacy questionnaires and clinical examinations are conducted.

Being tested
3D-printed cast, Conventional cast
Keywords
Distal Radius Fracture, 3D-Printing
Medical subject headings
Wrist Fractures

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • 3D-printed castDevice

    The 3D-printed casts are produced using 3D print technology based on software by Belgian software company: The patient's forearm is scanned with a tablet (duration: approx. 5 min), whereupon the cast is printed overnight according to the scan (duration: approx. 4h) and adjusted to the patient during the next appointment.

  • Conventional castDevice

    A conventional plaster cast is applied for treatment of the distal radius fracture.

Study groups in NCT05346926
Study groupRoleWhat they receive
3D-printed castExperimentalTreatment of distal radius fracture with 3D-printed forearm cast.
Receives: Device: 3D-printed cast
Conventional castActive comparatorTreatment of distal radius fracture with conventional plaster cast.
Receives: Device: Conventional cast

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Score of modified patient satisfaction questionnaire

    quantified with questionnaire (0-12, 0=worst result)

    Measured: 1 year

  2. Score of clinical effectiveness questionnaire

    quantified with questionnaire (0-12, 0=worst result)

    Measured: 1 year

Secondary outcomes (5)
  1. Fracture healing

    assessed with X-ray pictures taken during the follow-up, consolidation signs

    Measured: 1 year

  2. Score on Visual Analogue Pain Scale

    assessed using the Visual Analogue Pain Scale (0-10, 0=best result, no pain)

    Measured: 1 year

  3. Amount of range of motion in degrees

    assessed/measured by the physician with a goniometer (°, 0-360°)

    Measured: 1 year

  4. Amount of grip strength in (N/kg)

    assessed with a dynamometer (N/kg, the lower the weaker)

    Measured: 1 year

  5. Score of Disabilities of Arm, Shoulder and Hand

    assessed with Disabilities of Arm, Shoulder and Hand score (0-100, 0=best result, no impairment)

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Apr 2022
  2. Study start1 Mar 2020
  3. Primary completion31 Dec 2021
  4. Study completion31 Dec 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05346926
Sponsor's protocol ID
2019-01644
Other IDs
2019
Acronym
3D-cast
Status last verified
Apr 2022
First submitted
17 Apr 2022
Last updated
26 Apr 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing 3D-printed cast and Conventional cast in people with Radius Fracture Distal, run by Alissa Gubeli at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Apr 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Score of modified patient satisfaction questionnaire (time frame: 1 year). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Apr 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in